Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome.

about

Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome.

Item

http://www.wikidata.org/entity/Q51155090

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Atopy in children with systemi ...... sociated with a worse outcome.

@en

Atopy in children with systemic onset juvenile idiopathic arthritis

@nl

type

Item

label

Atopy in children with systemi ...... sociated with a worse outcome.

@en

Atopy in children with systemic onset juvenile idiopathic arthritis

@nl

prefLabel

Atopy in children with systemi ...... sociated with a worse outcome.

@en

Atopy in children with systemic onset juvenile idiopathic arthritis

@nl

P1476

Atopy in children with systemi ...... sociated with a worse outcome.

@en

P2093

Lan-Fang Cao

http://www.w3.org/2001/XMLSchema#string

Ling-Yun Xu

http://www.w3.org/2001/XMLSchema#string

Wen-Ming Zhang

http://www.w3.org/2001/XMLSchema#string

Yan-ming Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

Functional diversity of helper T lymphocytes

Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?

Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features.

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis

The prevalence of atopy in asthmatic children correlates strictly with the prevalence of atopy among nonasthmatic children.

P304

176-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08923973.2014.898068

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24611751

http://www.w3.org/2001/XMLSchema#string

P921

systemic-onset juvenile idiopathic arthritis

juvenile rheumatoid arthritis